https://members2.ecri.org/Components/forecast/Copyright 2010 ECRINew and Updated Forecast profilesen-us7/31/2010 4:21:22 PM7/31/2010 4:21:22 PM5htais@ecri.orghttps://members2.ecri.org/Components/Forecast/Pages/12079.aspx Researchers at the Children's Hospital of Boston (Boston, MA, USA) launched a phase I/II clinical trial of genetic treatment for a rare, inherited disorder, according to a hospital press release.7/23/2010https://members2.ecri.org/Components/Forecast/Pages/12080.aspx A U.S. Food and Drug Administration advisory panel voted in favor to keep the controversial type II diabetes mellitus (T2DM) drug rosiglitazone (Avandia, GlaxoSmithKline [GSK], London, UK) on the market, but with additional warnings of cardiovascular and other risks.7/23/2010https://members2.ecri.org/Components/Forecast/Pages/8031.aspx Making surgery less invasive continues to be the main trend in surgery in all clinical service lines and patient populations. Minimally invasive surgery appeals to patients by offering the potential benefits of less pain, quicker discharge from hospital, quicker recovery at home and return to activities of daily living, reduced blood loss, lower risk of infection, and smaller and fewer surgical scars.7/20/2010https://members2.ecri.org/Components/Forecast/Pages/11602.aspx For many patients with epilepsy, pharmacologic therapy is effective at achieving remission, which is defined as five or more years without a seizure while on medication. When drugs fail to control the disease, other treatment options include neurosurgery, vagus nerve stimulation, and a ketogenic diet.7/13/2010https://members2.ecri.org/Components/Forecast/Pages/11592.aspx Current treatment options for melanoma include surgery, radiation therapy, immunotherapy, and chemotherapy. However, these treatments have not been shown to significantly improve overall survival in patients with melanoma.7/12/2010